Ally Bridge Group (NY) LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001822947
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 17 positions · Total reported value $75.30M · Top-10 concentration 88.8% · Updated 2026-11-17
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
Turnover: 75.9% · 4 new · 6 cut · 12 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -15.8% · vs SPY -17.9% · Prev Value $113.07M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -16.4% · vs SPY -18.5% · Latest Value $75.30M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, Ally Bridge Group (NY) LLC disclosed 17 equity positions with a combined reported value of $75.30M. The filing implies a focused portfolio: its ten largest positions account for 88.8% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were DFTX ($15.22M), ABVX ($12.38M), EWTX ($7.53M). By sector, the heaviest allocations are Health Care 100.0%.
Versus the prior quarter, Ally Bridge Group (NY) LLC opened 4 new positions, trimmed 6 and fully exited 12, a turnover rate of 75.9% of positions. The portfolio's overlap with the prior quarter was 45% of names.
The largest new positions opened in Q3 2026 were AMLX ($5.30M), STTK ($4.26M), VRDN ($4.15M).
Of the 12 positions fully exited versus the prior quarter, the largest were TRAX ($5.72M), AXSM ($4.04M), WHWK ($3.75M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
Fully Exited (vs previous quarter)
- TRAX FIRST TRACKS BIOTHERAPEUTICS · prev qtr: $5.72M
- AXSM AXSOME THERAPEUTICS INC. · prev qtr: $4.04M
- WHWK WHITEHAWK THERAPEUTICS INC · prev qtr: $3.75M
- CLYM CLIMB BIO INC · prev qtr: $3.25M
- KURA KURA ONCOLOGY INC · prev qtr: $3.18M
- CTMX CYTOMX THERAPEUTICS INC. · prev qtr: $2.91M
- PALI PALISADE BIO INC · prev qtr: $2.57M
- SLDB SOLID BIOSCIENCES INC · prev qtr: $2.56M
Insider Transactions (Form 4)
Latest Ally Bridge Group (NY) LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Ally Bridge Group (NY) LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 17 US equity positions with a combined value of $75.30M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-121984 (status: Approved), registered 2021-07-30
- Regulatory AUM (Form ADV): $218.95M as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 3 hedge funds
Portfolio Structure
- 17 positions · $75.30M reported value (Q3 2026)
- Top 10 holdings = 88.8% of reported value
- Largest position: DFTX (DEFINIUM THERAPEUTICS INC) at 20.2%
- Average position size: $4.43M
Sector Tilt
- Health Care 100.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q3 2026: 4 new, 2 added, 6 reduced, 12 exited
- 5 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
400.00K | $15.22M | 20.22% | Hold | |
| 2 |
|
125.00K | $12.38M | 16.44% | Hold | |
| 3 |
|
185.43K | $7.53M | 10.00% | Add | |
| 4 |
|
620.32K | $6.73M | 8.94% | Hold | |
| 5 |
|
1.66M | $5.55M | 7.37% | Reduce | |
| 6 |
|
182.00K | $5.30M | 7.03% | New | |
| 7 |
|
625.19K | $4.26M | 5.66% | New | |
| 8 |
|
302.45K | $4.15M | 5.51% | New | |
| 9 |
|
400.00K | $2.96M | 3.92% | Add | |
| 10 |
|
526.32K | $2.80M | 3.72% | Hold | |
| 11 |
|
231.12K | $2.10M | 2.79% | Reduce | |
| 12 |
|
2.00M | $2.08M | 2.76% | New | |
| 13 |
|
134.43K | $2.06M | 2.74% | Reduce | |
| 14 |
|
227.25K | $838.55K | 1.11% | Reduce | |
| 15 |
|
786.24K | $466.87K | 0.62% | Hold | |
| 16 |
|
163.63K | $449.99K | 0.60% | Reduce | |
| 17 |
|
18.30K | $429.82K | 0.57% | Reduce | |
FAQ
What did Ally Bridge Group (NY) LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, Ally Bridge Group (NY) LLC reported 17 equity positions worth $75.30M in aggregate; its largest disclosed positions were DFTX ($15.22M), ABVX ($12.38M), EWTX ($7.53M).
How large is Ally Bridge Group (NY) LLC's portfolio?
Ally Bridge Group (NY) LLC reported $75.30M of long equity holdings across 17 positions as of 2026-Q3. Top-10 holdings account for 88.8% of reported value.
What is Ally Bridge Group (NY) LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.